Trials / Completed
CompletedNCT06014008
Effect of L. Paracasei Strain Shirota on Constipation in Healthy US Adults
The Effect of Lacticaseibacillus Paracasei Strain Shirota (LcS) in Healthy US Individuals Suffering From Hard or Lumpy Stools: A Randomized Controlled Open Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- Yakult U.S.A. Inc. · Industry
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to investigate the efficacy of daily consumption of a fermented milk containing LcS in reducing the frequency of bowel movement with hard or lumpy stools in generally healthy U.S. adult population with intermittent bowel movements producing hard or lumpy stools.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Test product consumption group | Participants will take one bottle (80 ml) of Yakult® drink daily for a period of 4 weeks. Yakult is a branded probiotic drink with 8x10\^9 CFU Lacticaseibacillus paracasei strain Shirota. Subsequently, a two-week follow-up period will follow. |
Timeline
- Start date
- 2023-09-18
- Primary completion
- 2024-05-13
- Completion
- 2024-09-30
- First posted
- 2023-08-28
- Last updated
- 2024-10-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06014008. Inclusion in this directory is not an endorsement.